4.7 Article

Free fatty acid kinetics in the late phase of postexercise recovery: importance of resting fatty acid metabolism and exercise-induced energy deficit

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 58, Issue 9, Pages 1248-1255

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2009.03.023

Keywords

-

Funding

  1. National Institutes of Health (NIH) [AR 49869, HD 057796, DK 56341, RR 00954]
  2. National Center for Research Resources [UL 1 RR024992]
  3. NIH and NIH Roadmap for Medical Research
  4. American Heart Association [0365436Z, 0510015Z]

Ask authors/readers for more resources

Free fatty acid (FFA) availability increases several-fold during exercise and remains significantly elevated for at least 3 to 6 hours after exercise cessation. Little, however, is known regarding the duration of the postexercise rise in FFA flux. In the present study, we used stable isotope-labeled palmitate infusion to examine fatty acid metabolism in 27 healthy untrained men and women (age, 29 7 years; body mass index, 25 +/- 4 kg/m(2)) between 13 to 16 hours and 21 to 24 hours after a single bout of moderate-intensity endurance exercise (1-2 hours at 60% of peak oxygen consumption), performed in the evening, and after a time-matched resting trial. Postabsorptive FFA rate of appearance (Ra) and FFA concentration in plasma were significantly greater after exercise than rest throughout the recovery period (P < .015), but the exercise-induced increases declined from approximately 40% at 13 to 16 hours to approximately 10% at 21 to 24 hours postexercise (P = .001). The magnitude of the exercise-induced increase in plasma FFA concentration was proportional to the increase in FFA Ra. Correlation analysis demonstrated that exercise-induced changes in plasma FFA Ra at 13 to 16 hours are (1) negatively associated with resting plasma FFA Ra and (2) positively associated with the net energy expenditure of exercise and the exercise-induced changes in whole-body fat oxidation rate (all P values < .05). In multivariate stepwise linear regression analysis, baseline plasma FFA Ra (P <= .008) and net energy expenditure of exercise (P <= .005) independently predicted the exercise-induced change in plasma FFA Ra at 13 to 16 hours. We conclude that the exercise-induced increase in FFA mobilization is (1) long-lived, persisting for 12 to 24 hours after exercise, with a progressive decline with time; (2) greater in subjects with low than high resting plasma FFA availability; and (3) greater after exercise with high than low energy demand. (C) 2009 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Physiology

EVOLUTION OF THE DIAGNOSTIC VALUE OF THE SUGAR OF THE BLOOD: HITTING THE SWEET SPOT TO IDENTIFY ALTERATIONS IN GLUCOSE DYNAMICS

Faidon Magkos, Dominic N. Reeds, Bettina Mittendorfer

Summary: This paper provides an overview of the evolution of hyperglycemia definition and the changes in glucose dynamics that lead to fasting and postprandial hyperglycemia. Extensive research has contributed to our understanding of different types of hyperglycemia, such as prediabetes and diabetes, and their subtypes, as well as their relationships with medical complications and strategies for prevention and treatment.

PHYSIOLOGICAL REVIEWS (2023)

Review Oncology

Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges

Dimitrios Tsilingiris, Narjes Nasiri-Ansari, Nikolaos Spyrou, Faidon Magkos, Maria Dalamaga

Summary: This article provides an overview of the association between obesity and hematological cancers and their role as risk factors for severe COVID-19. It also reviews the challenges faced by patients with hematologic malignancies during the pandemic, including the treatment of the underlying disease and the management of SARS-CoV-2 infection. Furthermore, the unresolved issues and future challenges for the management of hematologic malignancies in the era of COVID-19 are discussed.

CANCERS (2022)

Article Endocrinology & Metabolism

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health

Irene Karampela, Natalia Vallianou, Faidon Magkos, Caroline M. Apovian, Maria Dalamaga

Summary: This review emphasizes the epidemiological impact of obesity and hypovitaminosis D in the context of the ongoing COVID-19 pandemic. Obesity and hypovitaminosis D are independently associated with COVID-19 infection, severity of disease, and poor outcomes.

CURRENT OBESITY REPORTS (2022)

Review Biochemistry & Molecular Biology

Fermented Foods in the Management of Obesity: Mechanisms of Action and Future Challenges

Mahsa Jalili, Maryam Nazari, Faidon Magkos

Summary: Fermented foods, rich in probiotics and prebiotics, are widely consumed in many countries and populations. They can improve digestion, enhance immunity, and aid in weight loss, making them a potential tool for combating obesity. This article provides a comprehensive overview of the health effects of fermented foods and their mechanisms of action in obesity and related metabolic abnormalities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Oncology

Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes

Christian Sumeghy Sondergaard, Paulina Nunez Esquivel, Maria Dalamaga, Faidon Magkos

Summary: Diabetes patients may have an altered risk of cancer when using antihyperglycemic medications. Certain medications are associated with a lower risk of cancer, while others may increase the risk.

CURRENT ONCOLOGY REPORTS (2023)

Review Food Science & Technology

Omics biomarkers and an approach for their practical implementation to delineate health status for personalized nutrition strategies

Jaap Keijer, Xavier Escote, Sebastia Galmes, Andreu Palou-March, Francisca Serra, Mona Adnan Aldubayan, Kristina Pigsborg, Faidon J. Magkos, Ella C. Baker, Philip Calder, Joanna Goralska, Urszula Razny, Malgorzata Malczewska-Malec, David Sunol, Mar A. Galofre, Miguel Rodriguez, Nuria G. Canela, Radu Malcic, Montserrat Bosch, Claudia Favari, Pedro Mena, Daniele Del Rio, Antoni Caimari, Biotza M. Gutierrez, Josep del Bas

Summary: Personalized nutrition (PN) is a tool that empowers consumers to make dietary changes, improve health, and prevent diet-related diseases. However, the implementation of PN faces obstacles due to the complexity of individual metabolic characterization. This study proposes a conceptual framework that focuses on dysregulation of key processes and specific markers to assess metabolic health. Machine learning and data analysis algorithms can integrate omics and genetic markers, and digital tools can simplify their implementation.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2023)

Article Nutrition & Dietetics

Effects of Mindful Eating and YogaDance among Overweight and Obese Women: An Exploratory Randomized Controlled Trial

Sofie Hauerberg Henninger, Anna Yde Fibieger, Faidon Magkos, Christian Ritz

Summary: Current treatment options for overweight and obesity rely on strict diet and exercise regimes, making it difficult to sustain as a lifelong routine. This study explored the effects of mindful eating and YogaDance, individually and in combination, as alternative approaches to manage obesity. The findings suggest modest benefits of an 8-week combination of mindful eating and YogaDance, supporting previous research on the effectiveness of mindful eating, yoga, and dance.

NUTRIENTS (2023)

Article Pediatrics

Gestational weight gain in women with pre-pregnancy overweight or obesity and anthropometry of infants at birth

Christina Sonne Mogensen, Helle Zingenberg, Jens Svare, Arne Astrup, Faidon Magkos, Nina Rica Wium Geiker

Summary: This study analyzed data from 208 mothers and examined the association of gestational weight gain (GWG) among women with pre-pregnancy overweight or obesity with infant weight and BMI z-score at birth. The results showed that limiting GWG by 1 kg was associated with lower birthweight, BMI z-score, weight z-score, and infant abdominal circumference. Additionally, GWG below the Institute of Medicine guideline of a maximum of 9 kg was associated with lower birthweight and fewer emergency cesarean deliveries.

FRONTIERS IN PEDIATRICS (2023)

Article Medicine, Research & Experimental

Heterogeneity in the effect of marked weight loss on metabolic function in women with obesity

Bettina Mittendorfer, Brandon D. Kayser, Mihoko Yoshino, Jun Yoshino, Jeramie D. Watrous, Mohit Jain, J. Christopher Eagon, Bruce W. Patterson, Samuel Klein

Summary: This study evaluated the metabolic effects of weight loss in women with obesity and found that the heterogeneity in the effect of weight loss on muscle and hepatic insulin sensitivity is determined by baseline insulin action.

JCI INSIGHT (2023)

Article Nutrition & Dietetics

Supplementation with inulin-type fructans affects gut microbiota and attenuates some of the cardiometabolic benefits of a plant-based diet in individuals with overweight or obesity

Mona Adnan Aldubayan, Xiaotian Mao, Martin Frederik Laursen, Kristina Pigsborg, Lars H. Christensen, Henrik M. Roager, Dennis S. Nielsen, Mads Fiil Hjorth, Faidon Magkos

Summary: This study found that a high fiber plant-based diet can reduce body weight and improve cardiometabolic health in individuals with obesity. Additionally, the addition of inulin-type fructans (ITF) can alter gut microbiota composition and attenuate some of the realized cardiometabolic benefits.

FRONTIERS IN NUTRITION (2023)

Review Nutrition & Dietetics

Compensatory Responses to Exercise Training As Barriers to Weight Loss: Changes in Energy Intake and Non-exercise Physical Activity

Julie Marvel Mansfeldt, Faidon Magkos

Summary: This paper reviews studies on the changes in non-exercise physical activity (NEPA) in response to exercise-induced energy expenditure. The majority of studies show a compensatory decrease in NEPA upon starting a structured exercise training program, which may attenuate the energy deficit caused by exercise and prevent weight loss.

CURRENT NUTRITION REPORTS (2023)

Editorial Material Endocrinology & Metabolism

Effect of dietary carbohydrate restriction on cardiometabolic function in type 2 diabetes: weight loss and beyond

Faidon Magkos, Anahita Ataran, Ali Javaheri, Bettina Mittendorfer

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2023)

Article Endocrinology & Metabolism

Asian females without diabetes are protected from obesity-related dysregulation of glucose metabolism compared with males

Michelle H. H. Lee, Eveline Febriana, Maybritte Lim, Sonia Baig, Jeffrey B. B. Halter, Faidon Magkos, Sue-Anne Toh

Summary: This study aimed to investigate the effect of sex on obesity-driven changes in the mechanisms regulating glucose metabolism. The results showed that the adverse effects of obesity on insulin action and secretion were more pronounced in males than females, and females had greater insulin sensitivity and lower insulin secretion compared to males among participants with obesity.

OBESITY (2023)

Article Nutrition & Dietetics

Predicting weight loss success on a new Nordic diet: an untargeted multi-platform metabolomics and machine learning approach

Kristina Pigsborg, Valdemar Stentoft-Larsen, Samuel Demharter, Mona Adnan Aldubayan, Alessia Trimigno, Bekzod Khakimov, Soren Balling Engelsen, Arne Astrup, Mads Fiil Hjorth, Lars Ove Dragsted, Faidon Magkos

Summary: A predictive model was developed using machine learning to predict successful weight loss on a New Nordic Diet. The study found that individual responses to weight loss vary and the optimal diet for successful weight loss may differ for different individuals. This research is important for improving precision dietary treatment for obesity.

FRONTIERS IN NUTRITION (2023)

Article Endocrinology & Metabolism

Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes

Sasha A. S. Kjeldsen, Mads N. Thomsen, Mads J. Skytte, Amirsalar Samkani, Michael M. Richter, Jan Frystyk, Faidon Magkos, Elizaveta Hansen, Henrik S. Thomsen, Jens J. Holst, Sten Madsbad, Steen B. Haugaard, Thure Krarup, Nicolai J. Wewer Albrechtsen

Summary: This study aimed to investigate the dependency of body weight loss following a reduction in hepatic steatosis on markers of glucagon resistance in type 2 diabetes. The results showed that weight loss may contribute to the improvement of glucagon resistance in individuals with type 2 diabetes.

JOURNAL OF THE ENDOCRINE SOCIETY (2023)

Article Endocrinology & Metabolism

Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation

Emilie Steinbach, Davide Masi, Agnes Ribeiro, Patricia Serradas, Tiphaine Le Roy, Karine Clement

Summary: The study of the gut microbiome is crucial for understanding and treating metabolic diseases. While research on the fecal microbiome has provided valuable insights, relying solely on this may not be enough to draw comprehensive conclusions. The microbiome in the proximal part of the small intestine may play a significant role in metabolic regulation, but further exploration is needed due to limited accessibility.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4

Evangelia Chavdoula, Vollter Anastas, Alessandro La Ferlita, Julian Aldana, Giuseppe Carota, Mariarita Spampinato, Burak Soysal, Ilaria Cosentini, Sameer Parashar, Anuvrat Sircar, Giovanni Nigita, Lalit Sehgal, Michael A. Freitas, Philip N. Tsichlis

Summary: This study reveals the important role of KDM2B in triple-negative breast cancer (TNBC). KDM2B affects cellular resistance to oxidative stress by regulating a network of genes and metabolic enzymes, in collaboration with ATF4 and MYC. Additionally, high expression of KDM2B is associated with poor prognosis in patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

Statin therapy in individuals with intermediate cardiovascular risk

Joongmin Kim, Hyeongsoo Kim, Sang Hyun Park, Yura Kang, Kyungdo Han, Sang-Hak Lee

Summary: This study aimed to investigate the optimal LDL-C level after statin therapy in individuals with intermediate cardiovascular risk. The results showed that achieving LDL-C levels <120 mg/dL after statin therapy could lower the event risk.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Glucocorticoids and intrauterine programming of nonalcoholic fatty liver disease

Ze Chen, Li -Ping Xia, Lang Shen, Dan Xu, Yu Guo, Hui Wang

Summary: Accumulating evidence suggests that NAFLD has an intrauterine origin, with adverse prenatal environments and glucocorticoid exposure playing a crucial role in the developmental programming of fetal hepatic lipid metabolism. The offspring's glucocorticoid-insulin-like growth factor 1 (GC-IGF1) axis is programmed in utero, leading to postnatal catch-up growth and disrupted glucose and lipid metabolism, increasing susceptibility to NAFLD. Mismatch between intrauterine and postnatal environments can further disturb the programmed endocrine axes and accelerate the onset of NAFLD.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Article Endocrinology & Metabolism

CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease

Fuwen Zuo, Youzhao Wang, Xinlei Xu, Ruihao Ding, Wei Tang, Yu Sun, Xiaojie Wang, Yan Zhang, Jichao Wu, Yusheng Xie, Min Liu, Ziying Wang, Fan Yi

Summary: This study investigates the role of CCDC92 in the pathogenesis of diabetic kidney disease (DKD). The expression of CCDC92 was found to increase in kidney biopsies from patients with DKD and was correlated with glomerular lipid accumulation. Animal studies further confirmed the induction of CCDC92 in the kidney, particularly in podocytes, and the podocyte-specific deletion of Ccdc92 ameliorated podocyte injury and lipid deposition. CCDC92 was shown to promote podocyte lipotoxicity through ABCA1 signaling-mediated lipid homeostasis. Therefore, CCDC92 may serve as a potential biomarker of podocyte injury in DKD and targeting CCDC92 could be an innovative therapeutic strategy for DKD patients.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

Review Endocrinology & Metabolism

Brown adipose tissue-derived metabolites and their role in regulating metabolism

Khanyisani Ziqubu, Phiwayinkosi Dludla, Sihle E. Mabhida, Babalwa U. Jack, Susanne Keipert, Martin Jastroch, Sithandiwe E. Mazibuko-Mbeje

Summary: The discovery and revival of brown adipose tissue (BAT) in adult humans have opened up new possibilities for treating obesity and metabolic diseases. BAT not only plays a role in generating heat, but also secretes signaling molecules known as batokines, which regulate overall metabolism. This review highlights the importance of BAT-derived metabolites in controlling thermogenesis, substrate metabolism, and other biological processes, as well as their potential to alleviate obesity and related metabolic complications.

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)